HOME >> MEDICINE >> NEWS
Headlines about Herceptin show equality of access to costly drugs must be tackled

The recent press coverage on the use of Herceptin (brand name for the drug trastuzumab) for treating breast cancer in its early stages shows that issues of equal access to costly but effective drugs must be confronted, says an editorial in this week's BMJ.

Trastuzumab was "rapidly adopted as the standard of care" in the US for treating breast cancer, but one of the barriers to its use in other countries is its high cost, say the authors. In Canada the treatment costs $C50,000 a year (25,000) per patient, and despite its effectiveness was not approved for funding in Ontario until after a media backlash.

The drug represents the first of probably many new cancer treatments of this kind, say the authors. The new hope it gives to patients also highlights new cost issues - both for the drugs themselves and surrounding cost of treatment.

Equality of patient access must extend to these accompanying areas, for example in diagnosing suitability for the drugs. Recent UK figures, for instance, show that only half of women are currently tested for the cancer gene targeted by the new treatment.

Healthcare systems around the world must no longer be left scrambling when effective new treatments come on the market. Transparent, timely and appropriately funded processes must be in place if patients are to get equal access to the best new treatments, conclude the authors.


'"/>

Contact: Tersea Hagan
thagan@bma.org.uk
44-207-383-6174
BMJ-British Medical Journal
3-Nov-2005


Page: 1

Related medicine news :

1. Medical residents unclear about TB guidelines
2. Threats to hope -- Desperation affects reasoning about product information
3. Men worry more about penile size than women, says 60-year-old research review
4. New mothers often not asked about depression, UNC survey finds
5. Smart mice teach scientists about learning process, brain disorders
6. Fatalistic beliefs about cancer cause many to ignore cancer prevention advice
7. Food and drink, and what it says about us
8. Forensic pathologists tell physiologists what they know about death and what puzzles them
9. Medical students should be taught about rape
10. Survey reveals misperceptions about Alzheimers among African-American and Hispanic caregivers
11. What do we know about asthma in Africa?

Post Your Comments:
(Date:3/6/2015)... 06, 2015 The Gluten-Free Certification ... Association, is pleased to announce that Dufflet Pastries, ... has expanded their product line of gluten-free treats ... scrumptious and as satisfying as any of their ... and never contains hydrogenated fats or oils, artificial ...
(Date:3/6/2015)... March 06, 2015 FCPX developers ... Pixel Film Studios. , “Pro3rd Hue is a lower 3rd ... CEO of Pixel Film Studios. “Blurring the line between professional ... Pro3rd Hue is a set of 30 customizable lower third ... With Pro3rd Hue, FCPX users can complement any design with ...
(Date:3/6/2015)... 06, 2015 The producers of Health ... dates for Spokane, Washington and vicinity. This is a city ... and dine, and many outdoor activities. It is also a ... economy. Six major hospitals call the city home and provide ... The medically-focused cable TV program will be broadcast on CBS ...
(Date:3/6/2015)... Fluid Running® Owner, Jennifer Conroyd, an ... Fluid Running® method 3 years ago when ... She hit upon the trifecta of combining matched-bpm music, ... maximum-resistance, deep water running technique. She not only completed ... running workout that made the experience both enjoyable and ...
(Date:3/6/2015)... As the Mayo Clinic's 2012 published ... & Associates Nationwide Legal Services, A.P.C., comments on these ... Verduzco v. Daiichi Sankyo, Inc., Case No. 3:15-cv-159, in ... “In light of a recently filed lawsuit, Ford & ... and explore the Mayo Clinic's Benicar case study findings ...
Breaking Medicine News(10 mins):Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4Health News:A New Plugin Entitled Pro3rd Hue was Released Today from Pixel Film Studios Exclusively for FCPX 2Health News:The Health Briefs TV Show to Air in Spokane, Washington 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4
(Date:3/5/2015)... NEW YORK , March 5, 2015 /PRNewswire/ ... developing novel therapies for the treatment of chronic ... clinicians and researchers to advisory roles. The panel ... Relmada,s development programs and efforts to advance the ... chronic pain. They bring expertise in a range ...
(Date:3/5/2015)... , March 5, 2015 ... pressphoto agency ( http://www.epa.eu ) - ... lancio della nuova generazione di OASIS* all,ECR 2015. Si ... ad alto campo da 1.2 T che migliora la ... nuovo traguardo nell,attenzione al comfort del paziente. Le nuove ...
(Date:3/5/2015)... HAMPTON, N.J. , March 5, 2015 /PRNewswire/ ... ), a leading global specialty biopharmaceutical company, and Ikaria, ... they have entered into a definitive agreement under which ... a Madison Dearborn -led investor group in a ... Subject to customary closing conditions, the parties expect the ...
Breaking Medicine Technology:Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 2Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 3Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9
Cached News: